Literature DB >> 22963050

Stabilization of multiple metastatic epithelioid sarcoma under treatment with sunitinib malate.

P Penot, J-D Bouaziz, M Battistella, D Kerob, C Pagès, C Vilmer, N Basset-Seguin, N Madjessli, C Comte, C Farges, M Bagot, C le Maignan, C Lebbé.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 22963050     DOI： 10.1111/bjd.12038

Source DB:  PubMed          Journal:  Br J Dermatol        ISSN： 0007-0963            Impact factor:   9.302


× No keyword cloud information.
  4 in total

1.  Role of the lean body mass and of pharmacogenetic variants on the pharmacokinetics and pharmacodynamics of sunitinib in cancer patients.

Authors:  C Narjoz; A Cessot; A Thomas-Schoemann; J L Golmard; O Huillard; P Boudou-Rouquette; A Behouche; F Taieb; J P Durand; A Dauphin; R Coriat; M Vidal; M Tod; J Alexandre; M A Loriot; F Goldwasser; B Blanchet
Journal:  Invest New Drugs       Date:  2014-10-25       Impact factor: 3.850

2.  Sunitinib for patients with locally advanced or distantly metastatic dermatofibrosarcoma protuberans but resistant to imatinib.

Authors:  Yan Fu; Huanrong Kang; Hui Zhao; Jia Hu; Huanhuan Zhang; Xiaosong Li; Nan Du; Yitao Huang
Journal:  Int J Clin Exp Med       Date:  2015-05-15

Review 3.  Epithelioid Sarcoma: Opportunities for Biology-Driven Targeted Therapy.

Authors:  Jonathan Noujaim; Khin Thway; Zia Bajwa; Ayeza Bajwa; Robert G Maki; Robin L Jones; Charles Keller
Journal:  Front Oncol       Date:  2015-08-17       Impact factor: 6.244

4.  A metastatic distal-type epithelioid sarcoma: Case report and review.

Authors:  Avalon Regalbuto; Andrew Tudosie; Eveline Klenotic
Journal:  Int J Surg Case Rep       Date:  2020-05-16
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.